One Health National Action Plan on Antimicrobial Resistance 2022 to 2025.

The One Health National Action Plan on Antimicrobial Resistance is the updated version of the National Antimicrobial Resistance Action Plan of 2015. The timeframe of this Plan covers the period between 2022 and 2025. The One Health NAP against Antimicrobial Resistance (AMR) lays down sustainable actions towards containing AMR in animal, environmental and human health sectors. The strategic objectives of this Plan are: (I) improving awareness and understanding of antimicrobial resistance through effective communication, education and training; (II) strengthening nationally coordinated and integrated surveillance system; (III) reducing the incidence of antimicrobial resistance events in human, animal and environmental health through improved infection, prevention and control practices; (IV) optimizing the use of antimicrobial medicines in human and animal health; and (V) establishing and ensuring governance, sustainable investment, innovation and actions to combat antimicrobial resistance using the One Health Approach.
The awareness and understanding on matters relating to antimicrobial resistance will be improved by increasing the number of communities trained on AMR using the One Health Approach; including One Health on Antimicrobial Resistance Concepts as a core component of professional education of health professionals in animal, environmental and human health sectors; and conducting training on the use of Standard Therapeutic Guidelines (STGs), antibiotic protocols and infection control protocols. A National Strategic Health Communication and Community Engagement on One Health Approach for Antimicrobial Resistance Plan will be developed. Actions will be taken towards establishing a National One Health Reference Laboratory and integrated surveillance system in 2030. AMR related research will be conducted with a multisectoral approach, and the surveillance on antimicrobial usage will be conducted to understand the type of antimicrobials used and develop policies or consumer information on social media for different target populations in all sectors to help reduce misuse and abuse of antimicrobials. Antimicrobial resistance will be controlled by advocating, facilitating and promoting programs related to surveillance, optimal antimicrobial use and infection prevention and control. One Health Approach will be incorporated in all infection prevention control programs. The Implementation of infection prevention and control programs will be strengthened across all sectors to combat AMR, with an emphasis on animal, environmental and human health sectors.
The National Antimicrobial Resistance Committee will develop strategies to ensure the effectiveness of antimicrobial agents used in the treatment and prevention of infectious diseases in humans, animals, agriculture and environment. All imported antimicrobials for use in all sectors will be registered and regulated. The rate on importation and use of antibiotics as growth promoters in food producing animal feeds, will be reduced. The regulatory framework will be strengthened to enforce the sales of all antimicrobials for animals to be prescribed by registered veterinarians only. The availability and accessibility of prequalified antibiotics will be ensured. An integrated system for importation, use and waste management of antimicrobials will be developed. The policy and legal frameworks for the disposal of pharmaceutical products used in human and animal health will be updated. Antimicrobial List and Standard Treatment Guidelines will be developed for the animal health sector. One Health Approach will be used as priority health agenda in all sectors to establish and ensure governance, sustainable investment, innovation and actions to combat antimicrobial resistance. The access to credible and integrated AMR data as well as to best practice tools and applications will be improved to build evidence and innovation in One Health. Suitable investment cases will be identified for AMR using One Health Approach. The Fiji National Action Plan against Antimicrobial Resistance 2022-2025 will be reviewed and updated before the end of 2025 after the planned impact analysis.